CH445129A
(fr)
|
1964-04-29 |
1967-10-15 |
Nestle Sa |
Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
|
US3459731A
(en)
|
1966-12-16 |
1969-08-05 |
Corn Products Co |
Cyclodextrin polyethers and their production
|
US3426011A
(en)
|
1967-02-13 |
1969-02-04 |
Corn Products Co |
Cyclodextrins with anionic properties
|
US3453257A
(en)
|
1967-02-13 |
1969-07-01 |
Corn Products Co |
Cyclodextrin with cationic properties
|
US3453259A
(en)
|
1967-03-22 |
1969-07-01 |
Corn Products Co |
Cyclodextrin polyol ethers and their oxidation products
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
ATE171185T1
(de)
|
1985-03-15 |
1998-10-15 |
Antivirals Inc |
Immunotestmittel für polynukleotid und verfahren
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
WO1993001286A2
(en)
|
1991-06-28 |
1993-01-21 |
Massachusetts Institute Of Technology |
Localized oligonucleotide therapy
|
EP0786522A2
(en)
|
1992-07-17 |
1997-07-30 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic RNA molecules for treatment of stenotic conditions
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
US5753613A
(en)
|
1994-09-30 |
1998-05-19 |
Inex Pharmaceuticals Corporation |
Compositions for the introduction of polyanionic materials into cells
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
IL115849A0
(en)
|
1994-11-03 |
1996-01-31 |
Merz & Co Gmbh & Co |
Tangential filtration preparation of liposomal drugs and liposome product thereof
|
US6245747B1
(en)
|
1996-03-12 |
2001-06-12 |
The Board Of Regents Of The University Of Nebraska |
Targeted site specific antisense oligodeoxynucleotide delivery method
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US7572582B2
(en)
|
1997-09-12 |
2009-08-11 |
Exiqon A/S |
Oligonucleotide analogues
|
WO1999042091A2
(en)
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
NZ514348A
(en)
|
1999-05-04 |
2004-05-28 |
Exiqon As |
L-ribo-LNA analogues
|
EP1242052A4
(en)
|
1999-12-29 |
2003-07-02 |
A James Mixson |
HISTIDIN COPOLYMER AND METHODS OF USE THEREOF
|
US7070807B2
(en)
|
1999-12-29 |
2006-07-04 |
Mixson A James |
Branched histidine copolymers and methods for using same
|
WO2003020739A2
(en)
|
2001-09-04 |
2003-03-13 |
Exiqon A/S |
Novel lna compositions and uses thereof
|
KR100464261B1
(ko)
|
2002-01-24 |
2005-01-03 |
주식회사 파나진 |
Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
KR20030084444A
(ko)
|
2002-04-26 |
2003-11-01 |
주식회사 파나진 |
Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
|
US7569575B2
(en)
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
AU2003291682A1
(en)
|
2002-11-05 |
2004-06-03 |
Isis Pharmaceuticals, Inc. |
2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
|
WO2004097017A2
(en)
|
2003-04-29 |
2004-11-11 |
Avi Biopharma, Inc. |
Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
|
US7211668B2
(en)
|
2003-07-28 |
2007-05-01 |
Panagene, Inc. |
PNA monomer and precursor
|
US8258109B2
(en)
|
2005-10-20 |
2012-09-04 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of LMNA expression
|
SI2735568T1
(en)
|
2006-05-10 |
2018-01-31 |
Sarepta Therapeutics, Inc. |
Analogues of the oligonucleotide, with cationic links between subunits
|
JP2010503707A
(ja)
*
|
2006-09-15 |
2010-02-04 |
エンゾン ファーマスーティカルズ インコーポレイテッド |
オリゴヌクレオチドの送達を目的としたヒンダードエステル系生体分解性リンカー
|
AU2008271050B2
(en)
|
2007-06-29 |
2014-11-06 |
Sarepta Therapeutics, Inc. |
Tissue specific peptide conjugates and methods
|
EP2167135A2
(en)
|
2007-07-12 |
2010-03-31 |
Prosensa Technologies B.V. |
Molecules for targeting compounds to various selected organs, tissues or tumor cells
|
CN101861318A
(zh)
|
2007-11-15 |
2010-10-13 |
Avi生物制药公司 |
合成吗啉代低聚物的方法
|
JP5645840B2
(ja)
|
2008-12-02 |
2014-12-24 |
株式会社Wave Life Sciences Japan |
リン原子修飾核酸の合成方法
|
CN102625840A
(zh)
|
2009-04-10 |
2012-08-01 |
肌肉学研究协会 |
用于治疗疾病的三环dna反义寡核苷酸、组合物和方法
|
US20110269665A1
(en)
*
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
CN102596204B
(zh)
|
2009-07-06 |
2016-11-23 |
波涛生命科学有限公司 |
新的核酸前药及其使用方法
|
EP2479182B8
(en)
|
2009-09-16 |
2016-07-13 |
Wave Life Sciences Japan, Inc. |
Novel protecting group for synthesizing rna and derivative thereof
|
ES2816898T3
(es)
*
|
2010-05-13 |
2021-04-06 |
Sarepta Therapeutics Inc |
Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
|
NZ603606A
(en)
*
|
2010-05-28 |
2015-06-26 |
Sarepta Therapeutics Inc |
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
|
EP2620428B1
(en)
|
2010-09-24 |
2019-05-22 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
ES2607603T3
(es)
|
2010-09-30 |
2017-04-03 |
Nippon Shinyaku Co., Ltd. |
Derivado de ácido morfolino nucleico
|
JP5653160B2
(ja)
|
2010-10-15 |
2015-01-14 |
ダンロップスポーツ株式会社 |
ゴルフボール
|
CN103619356B
(zh)
*
|
2011-05-05 |
2017-09-12 |
萨勒普塔医疗公司 |
肽寡核苷酸缀合物
|
US9161948B2
(en)
*
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
US9302014B2
(en)
|
2011-08-30 |
2016-04-05 |
Medical Research Council |
Cell-penetrating peptides having a central hydrophobic domain
|
DK2581448T3
(en)
|
2011-10-13 |
2015-04-27 |
Ass Inst De Myologie |
Tricyclo-DNA phosphorothioate
|
KR20140097398A
(ko)
|
2011-11-18 |
2014-08-06 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트
|
LT2788487T
(lt)
*
|
2011-12-08 |
2018-09-10 |
Sarepta Therapeutics, Inc. |
Oligonukleotido analogai, nukreipti į žmogaus lmna
|
CA2862628C
(en)
|
2012-01-27 |
2021-08-24 |
Prosensa Technologies B.V. |
Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
|
DE102012101676A1
(de)
|
2012-02-29 |
2013-08-29 |
Klaus-Dieter Rösler |
Verfahren und Vorrichtung zum Bearbeiten von Formularen mit einer Datenverarbeitungsanlage
|
WO2014012081A2
(en)
|
2012-07-13 |
2014-01-16 |
Ontorii, Inc. |
Chiral control
|
PL2872485T3
(pl)
|
2012-07-13 |
2021-05-31 |
Wave Life Sciences Ltd. |
Asymetryczna grupa pomocnicza
|
AU2014253960B2
(en)
*
|
2013-04-16 |
2020-06-18 |
Memorial Sloan-Kettering Cancer Center |
Age-modified cells and methods for making age-modified cells
|
EP3095460A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
US10160969B2
(en)
|
2014-01-16 |
2018-12-25 |
Wave Life Sciences Ltd. |
Chiral design
|
CA2948373A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Oregon State University |
Antisense antibacterial compounds and methods
|
CA2948568A1
(en)
*
|
2014-05-19 |
2015-11-26 |
David Greenberg |
Antisense antibacterial compounds and methods
|
WO2015179743A1
(en)
*
|
2014-05-23 |
2015-11-26 |
Genzyme Corporation |
Library and screening approach for improved cell penetrating peptides
|
BR112018072279A2
(pt)
*
|
2016-04-29 |
2019-02-12 |
Sarepta Therapeutics, Inc. |
análogos de oligonucleotídeo tendo como alvo lmna humana
|